Latest News & Features
Americas
Judges considered Hikma’s label and marketing material when overturning lower court’s decision | Court said Amarin had stated plausible claim for induced infringement of patents. 27 June 2024
Americas
Brazil’s updated regulations for its flagship partnerships programme marks a renewed effort to strengthen the nation's health sector, says Rob Rodrigues of RNA Law. 25 June 2024
Americas
US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss. 25 June 2024
Big Pharma
UK judge concludes neither party has ‘won’ in case between Salts and Pelican over ostomy products | Court denied Salts’ request for Model D disclosure. 25 June 2024
Americas
Magistrate stand-in not authorised to answer jury questions, says eleventh circuit in precedential opinion | Florida judge left to catch flight before verdict given | Dispute between shrimp breeders concerns “unique” breeding method. 20 June 2024
Americas
Can the FTC push through a law that has perturbed America’s life sciences industry? Unlikely, says the lawyer appointed by the world’s largest HR group opposing the move. 20 June 2024
Americas
South Korean firm has sued two manufacturers in Delaware alleging patent infringement | SKBP asked court to stop ANDAs from Aurobindo and Zenara until patents expire. 19 June 2024
Big Pharma
Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”. 18 June 2024
Europe
Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore. 18 June 2024
Big Pharma
New Jersey court grants 30-day stay days after ordering the removal of five patents for asthma inhalers from FDA Orange Book | Decision follows ruling favouring Amneal Pharmaceuticals, which argued the patents were improperly listed. 18 June 2024